Please use this identifier to cite or link to this item:
https://hdl.handle.net/1959.11/49207
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Le, Ngoc‑Anh | en |
dc.contributor.author | Diffenderfer, Margaret R | en |
dc.contributor.author | Thongtang, Nuntakorn | en |
dc.contributor.author | Ooi, Esther M M | en |
dc.contributor.author | Barrett, P Hugh R | en |
dc.contributor.author | Horvath, Katalin V | en |
dc.contributor.author | Dolnikowski, Gregory G | en |
dc.contributor.author | Asztalos, Bela F | en |
dc.contributor.author | Schaefer, Ernst J | en |
dc.contributor.author | Brown, W Virgil | en |
dc.date.accessioned | 2022-03-13T23:50:41Z | - |
dc.date.available | 2022-03-13T23:50:41Z | - |
dc.date.issued | 2015-05 | - |
dc.identifier.citation | Lipids, 50(5), p. 447-458 | en |
dc.identifier.issn | 1558-9307 | en |
dc.identifier.issn | 0024-4201 | en |
dc.identifier.uri | https://hdl.handle.net/1959.11/49207 | - |
dc.description.abstract | <p>Dose-associated effects of rosuvastatin on the metabolism of apolipoprotein (apo) B-100 in triacylglycerol rich lipoprotein (TRL, <i>d</i> < 1.019g/ml) and low density lipoprotein (LDL) and of apoA-I in high density lipoprotein (HDL) were assessed in subjects with combined hyperlipidemia. Our primary hypothesis was that maximal dose rosuvastatin would decrease the apoB-100 production rate (PR), as well as increase apoB-100 fractional catabolic rate (FCR). Eight subjects received placebo, rosuvastatin 5 mg/day, and rosuvastatin 40mg/day for 8weeks each in sequential order. The kinetics of apoB-100 in TRL and LDL and apoA-I in HDL were determined at the end of each phase using stable isotope methodology, gas chromatography-mass spectrometry, and multicompartmental modeling. Rosuvastatin at 5 and 40mg/day decreased LDL cholesterol by 44 and 54% (both <i>P</i> < 0.0001), triacylglycerol by 14% (ns) and 35% (<i>P</i> < 0.01), apoB by 30 and 36% (both <i>P</i> < 0.0001), respectively, and had no significant effects on HDL cholesterol or apoA-I levels. Significant decreases in plasma markers of cholesterol synthesis and increases in cholesterol absorption markers were observed. Rosuvastatin 5 and 40mg/day increased TRL apoB-100 FCR by 36 and 46% (both ns) and LDL apoB-100 by 63 and 102% (both <i>P</i> < 0.05), respectively. HDL apoA-I PR increased with low dose rosuvastatin (12%, <i>P</i> < 0.05) but not with maximal dose rosuvastatin. Neither rosuvastatin dose altered apoB-100 PR or HDL apoA-I FCR. Our data indicate that maximal dose rosuvastatin treatment in subjects with combined hyperlipidemia resulted in significant increases in the catabolism of LDL apoB-100, with no significant effects on apoB-100 production or HDL apoA-I kinetics.</p> | en |
dc.language | en | en |
dc.publisher | John Wiley & Sons Ltd | en |
dc.relation.ispartof | Lipids | en |
dc.title | Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner | en |
dc.type | Journal Article | en |
dc.identifier.doi | 10.1007/s11745-015-4005-0 | en |
local.contributor.firstname | Ngoc‑Anh | en |
local.contributor.firstname | Margaret R | en |
local.contributor.firstname | Nuntakorn | en |
local.contributor.firstname | Esther M M | en |
local.contributor.firstname | P Hugh R | en |
local.contributor.firstname | Katalin V | en |
local.contributor.firstname | Gregory G | en |
local.contributor.firstname | Bela F | en |
local.contributor.firstname | Ernst J | en |
local.contributor.firstname | W Virgil | en |
local.profile.school | Faculty of Medicine and Health | en |
local.profile.email | pbarret6@une.edu.au | en |
local.output.category | C1 | en |
local.record.place | au | en |
local.record.institution | University of New England | en |
local.publisher.place | United Kingdom | en |
local.format.startpage | 447 | en |
local.format.endpage | 458 | en |
local.identifier.scopusid | 84940008460 | en |
local.peerreviewed | Yes | en |
local.identifier.volume | 50 | en |
local.identifier.issue | 5 | en |
local.contributor.lastname | Le | en |
local.contributor.lastname | Diffenderfer | en |
local.contributor.lastname | Thongtang | en |
local.contributor.lastname | Ooi | en |
local.contributor.lastname | Barrett | en |
local.contributor.lastname | Horvath | en |
local.contributor.lastname | Dolnikowski | en |
local.contributor.lastname | Asztalos | en |
local.contributor.lastname | Schaefer | en |
local.contributor.lastname | Brown | en |
dc.identifier.staff | une-id:pbarret6 | en |
local.profile.orcid | 0000-0003-3223-6125 | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.identifier.unepublicationid | une:1959.11/49207 | en |
local.date.onlineversion | 2015-03-26 | - |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
local.title.maintitle | Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner | en |
local.relation.fundingsourcenote | The authors thank the staff of the Clinical Interaction Network of the Atlanta CTSI for their support and dedication in the conduct of the study. The authors are grateful to Dr. James Otvos and the technical staff at LipoScience for their assistance with the NMR analysis and to Dr. Eliana Polisecki and her staff at Boston Heart Diagnostics for their assistance with the plasma sterol analysis. The technical assistance of Wing-Yee Wan, Robert Matera, and Dr. Pimjai Anthanont is much appreciated. This research was supported by an investigator-initiated grant from AstraZeneca to Drs. N.-A. Le and W. V. Brown. Additional support was provided by PHS grant UL1 RR025008 from the National Institutes of Health (N.-A.L., W.V.B.), by US Department of Agriculture Research Service Contract 53-3K-06 (E.J.S.), and by Project Grant P50 HL083813-01 from the National Institutes of Health (E.J.S.). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or the US Department of Agriculture. P.H.R.B. is a fellow of the National Health and Medical Research Council of Australia; E.M.M.O., a postdoctoral research fellow of the National Health and Medical Research Council of Australia; and N.T., a postdoctoral research fellow from Siriraj Hospital, Mahidol University, Thailand. | en |
local.output.categorydescription | C1 Refereed Article in a Scholarly Journal | en |
local.search.author | Le, Ngoc‑Anh | en |
local.search.author | Diffenderfer, Margaret R | en |
local.search.author | Thongtang, Nuntakorn | en |
local.search.author | Ooi, Esther M M | en |
local.search.author | Barrett, P Hugh R | en |
local.search.author | Horvath, Katalin V | en |
local.search.author | Dolnikowski, Gregory G | en |
local.search.author | Asztalos, Bela F | en |
local.search.author | Schaefer, Ernst J | en |
local.search.author | Brown, W Virgil | en |
local.uneassociation | No | en |
local.atsiresearch | No | en |
local.sensitive.cultural | No | en |
local.identifier.wosid | 000353566200002 | en |
local.year.available | 2015 | en |
local.year.published | 2015 | en |
local.fileurl.closedpublished | https://rune.une.edu.au/web/retrieve/18257459-cbf4-42b0-a98f-66e0a98f7b3f | en |
local.subject.for2020 | 320101 Cardiology (incl. cardiovascular diseases) | en |
local.subject.seo2020 | 200105 Treatment of human diseases and conditions | en |
Appears in Collections: | Journal Article |
Files in This Item:
File | Size | Format | |
---|---|---|---|
closedpublished/RosuvastatinBarrett2015JournalArticle.pdf | 447.55 kB | Adobe PDF Download Adobe | View/Open |
SCOPUSTM
Citations
7
checked on Jun 8, 2024
Page view(s)
508
checked on Jul 23, 2023
Download(s)
24
checked on Jul 23, 2023
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.